Saturday, December 21, 2024
Home Tags HAPB

Tag: HAPB

Hapbee
Telehealth

Jim Kwik and Kevin Harrington Join Hapbee Technologies (HAPB) Board.

Editor / Curator -
HAPBEE
All News

Hapbee (HAPB): The Netflix of Feelings

Editor / Curator -
Hapbee, Biotech Stock Review
Telehealth

Scott Donnell Used His Intuition to Launch Hapbee (HAPB). Video.

Editor / Curator -
Internet Stock Review
Institutional Analyst Newsletter

Newsletter: Institutional Analyst. And Yes, We Have Another Double.

Editor / Curator -
Hapbee
All News

Hapbee’s (HAPB) Device, “Choose How You Feel.”

Editor / Curator -
Hapbee
Telehealth

Hapbee (HAPB) Provides Update. Over 1,800 Devices Delivered.

Editor / Curator -
Hapbee, Biotech Stock Review
All News

Hapbee Technologies (HAPB): Updates and News Archive.

Editor / Curator -
Hapbee, Biotech Stock Review
Telehealth

Hapbee (HAPB) Soars 136% the First Day of Trading!

Editor / Curator -
Hapbee, Biotech Stock Review
Accelerator

Telehealth App Hapbee (HAPB) Goes Public and More.

Editor / Curator -
Hapbee,
All News

Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.

Editor / Curator -
123Page 2 of 3

Latest article

Adding Quantum Pharmaceutical (QNTM) $4.10 to Reverse Split Stock Watch List.

All News Editor / Curator -
119% Gain Post Split

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.